Doctors and scientists in the United States have noticed that previous prostate-specific antigen (PSA)-based screenings may lead to an overdiagnosis for prostate cancer and have reduced the use of PSA for prostate cancer screening. The gene discussed is KLK3; the disease is prostate cancer.